Price Alert

NAYA Biosciences Inc. Com... (IVF)

NASDAQ: IVF · Real-Time Price · USD

1.57

-0.18 (-10.29%)

At close: Aug 15, 2025, 3:01 PM

NAYA Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-9.1M	-8.03M	-10.89M	-6.65M
Depreciation & Amortization	919.6K	200.89K	77.3K	166.08K
Stock-Based Compensation	1.59M	1.39M	2.22M	2.71M
Other Working Capital	501.67K	-388.67K	580.49K	-3.67M
Other Non-Cash Items	1.75M	1.21M	505.43K	1.36M
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	1.86M	471.7K	1.48M	-3.61M
Operating Cash Flow	-2.97M	-4.76M	-6.6M	-6.03M
Capital Expenditures	-183.7K	-444.72K	-12.73K	-454.65K
Cash Acquisitions	472.01K	-2.05M	-68.49K	-1.7M
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	75.59K	n/a	-1.94K	-38.94K
Investing Cash Flow	363.89K	-2.49M	-81.22K	-2.15M
Debt Repayment	409.83K	1.66M	800K	-250K
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	900.61K	25.43K	n/a	369.84K
Financial Cash Flow	3.12M	7.39M	1.09M	3.77M
Net Cash Flow	508.97K	142.29K	-5.59M	-4.41M
Free Cash Flow	-3.16M	-5.2M	-6.62M	-6.48M